France
· Delayed Price · Currency is EUR Valbiotis Statistics
Total Valuation
Valbiotis has a market cap or net worth of EUR 18.74 million. The enterprise value is 12.88 million.
| Market Cap | 18.74M |
| Enterprise Value | 12.88M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Valbiotis has 15.88 million shares outstanding. The number of shares has increased by 26.74% in one year.
| Current Share Class | 15.88M |
| Shares Outstanding | 15.88M |
| Shares Change (YoY) | +26.74% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 4.05% |
| Owned by Institutions (%) | 7.67% |
| Float | 15.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 106.49 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 2.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.28 |
| EV / Sales | 73.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.10 |
Financial Position
The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.55.
| Current Ratio | 3.04 |
| Quick Ratio | 2.57 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.49 |
| Interest Coverage | -45.33 |
Financial Efficiency
Return on equity (ROE) is -66.90% and return on invested capital (ROIC) is -30.62%.
| Return on Equity (ROE) | -66.90% |
| Return on Assets (ROA) | -24.63% |
| Return on Invested Capital (ROIC) | -30.62% |
| Return on Capital Employed (ROCE) | -74.17% |
| Revenue Per Employee | 4,000 |
| Profits Per Employee | -227,841 |
| Employee Count | 44 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 1.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.69% in the last 52 weeks. The beta is -0.30, so Valbiotis's price volatility has been lower than the market average.
| Beta (5Y) | -0.30 |
| 52-Week Price Change | -70.69% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 60.29 |
| Average Volume (20 Days) | 68,884 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Valbiotis had revenue of EUR 176,000 and -10.03 million in losses. Loss per share was -0.63.
| Revenue | 176,000 |
| Gross Profit | -2.16M |
| Operating Income | -10.43M |
| Pretax Income | -9.99M |
| Net Income | -10.03M |
| EBITDA | -10.31M |
| EBIT | -10.43M |
| Loss Per Share | -0.63 |
Balance Sheet
The company has 11.58 million in cash and 5.72 million in debt, giving a net cash position of 5.86 million or 0.37 per share.
| Cash & Cash Equivalents | 11.58M |
| Total Debt | 5.72M |
| Net Cash | 5.86M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 10.37M |
| Book Value Per Share | 0.66 |
| Working Capital | 11.33M |
Cash Flow
In the last 12 months, operating cash flow was -11.54 million and capital expenditures -147,000, giving a free cash flow of -11.68 million.
| Operating Cash Flow | -11.54M |
| Capital Expenditures | -147,000 |
| Free Cash Flow | -11.68M |
| FCF Per Share | -0.74 |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,923.86% |
| Pretax Margin | -5,676.70% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Valbiotis does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.74% |
| Shareholder Yield | n/a |
| Earnings Yield | -53.49% |
| FCF Yield | -62.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Valbiotis has an Altman Z-Score of 0.77. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.77 |
| Piotroski F-Score | n/a |